Jae Hwan Oh
Goyang-si, Gyeonggi-do, 410-769, South Korea
NCT Number: NCT01938027
The purpose of this study is evaluation of the safety and the efficacy of transanal total mesorectal excision.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Interventional
Not applicable
Goyang-si, Gyeonggi-do, 410-769, South Korea
Subjects will have their rectal cancer removed using a technique combining surgery through the anus and standard laparoscopy. Transanal visualization will be using endoscopy. At the end of the procedure, the rectum will be removed though the anus or ileostomy formation site, the bowel will be re-connected to the anus, and a temporary diverting stoma will be created, which is standard of care following surgery for this type of cancer.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Laparoscopy-assisted transanal total mesorectal excision
Time frame: 1-5 years
The quality of the mesorectum was determined using pathology reports and scored using three grades:
Time frame: 1-5 years
Time frame: 1-5 years
National Cancer Center, Korea
Other Gov
A Pilot Study for the Evaluation of the Safety and the Efficacy of Transanal Total Mesorectal Excision
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05513742
Colon Cancer, Colonic Diseases
Hot Springs, Arkansas, United States
View Trial DetailsNCT06426927
Colon Adenocarcinoma, Colon Cancer
Chapel Hill, North Carolina, United States
View Trial DetailsNCT04369053
Adenoma, Colon Cancer
Birmingham, Alabama, United States
View Trial DetailsNCT02965521
Colon Cancer, Colonic Diseases
San Francisco, California, United States
View Trial Details